Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.

Tyrrell KL, Citron DM, Merriam CV, Leoncio E, Goldstein EJC.

Anaerobe. 2018 Dec;54:39-41. doi: 10.1016/j.anaerobe.2018.04.010. Epub 2018 Apr 13.

PMID:
30096588
2.

Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02551-17. doi: 10.1128/AAC.02551-17. Print 2018 Apr.

3.

Comparative In Vitro Activities of Relebactam, Imipenem, the Combination of the Two, and Six Comparator Antimicrobial Agents against 432 Strains of Anaerobic Organisms, Including Imipenem-Resistant Strains.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01992-17. doi: 10.1128/AAC.01992-17. Print 2018 Feb.

4.

The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.

Goldstein EJ, Citron DM, Tyrrell KL, Leoncio ES, Merriam CV.

Anaerobe. 2017 Feb;43:1-3. doi: 10.1016/j.anaerobe.2016.09.008. Epub 2016 Oct 3.

PMID:
27713022
5.

Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 Oct;57(10):4872-6. doi: 10.1128/AAC.01136-13. Epub 2013 Jul 22.

6.
7.

Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.

Claros M, Citron DM, Goldstein EJ, Merriam CV, Tyrrell KL.

Diagn Microbiol Infect Dis. 2013 Aug;76(4):546-8. doi: 10.1016/j.diagmicrobio.2013.04.025. Epub 2013 May 30.

PMID:
23727512
8.

Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.

Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):347-51. doi: 10.1016/j.diagmicrobio.2013.03.019. Epub 2013 Apr 24.

PMID:
23623385
9.

In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 Jun;57(6):2620-30. doi: 10.1128/AAC.02418-12. Epub 2013 Mar 25.

10.

Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Antimicrob Agents Chemother. 2013 May;57(5):2401-4. doi: 10.1128/AAC.02580-12. Epub 2013 Mar 4.

11.

Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolates.

Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL.

Antimicrob Agents Chemother. 2012 Dec;56(12):6319-23. doi: 10.1128/AAC.01794-12. Epub 2012 Oct 1.

12.

Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2012 May;56(5):2493-503. doi: 10.1128/AAC.06305-11. Epub 2012 Jan 30.

13.

In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2012 Mar;56(3):1613-5. doi: 10.1128/AAC.05655-11. Epub 2011 Dec 19.

14.

Activity of garenoxacin against 536 unusual anaerobes including 128 recovered from acute pelvic infections.

Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.

Diagn Microbiol Infect Dis. 2011 May;70(1):131-6. doi: 10.1016/j.diagmicrobio.2010.12.006. Epub 2011 Mar 12.

PMID:
21398076
15.

In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.

Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2010 Apr;54(4):1627-32. doi: 10.1128/AAC.01788-09. Epub 2010 Jan 25.

16.

Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.

Goldstein EJ, Citron DM, Merriam CV, Abramson MA.

Surg Infect (Larchmt). 2009 Apr;10(2):111-8. doi: 10.1089/sur.2007.096.

PMID:
19226203
17.

In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2008 Feb;52(2):761-6. Epub 2007 Dec 10.

18.

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA.

J Clin Microbiol. 2007 Sep;45(9):2819-28. Epub 2007 Jul 3.

19.

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Nov;50(11):3959-62. Epub 2006 Sep 18.

20.

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Oct;50(10):3507-13. Epub 2006 Aug 28.

21.

Bacteriology of human bite wound infections.

Merriam CV, Fernandez HT, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ.

Anaerobe. 2003 Apr;9(2):83-6.

PMID:
16887692
22.

In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens.

Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ.

Int J Antimicrob Agents. 2006 Sep;28(3):244-8. Epub 2006 Jul 27.

PMID:
16875802
23.

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.

Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez HT.

Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9.

24.

In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.

Tyrrell KL, Citron DM, Warren YA, Fernandez HT, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2006 Aug;50(8):2728-31.

25.

In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis.

Citron DM, Tyrrell KL, Warren YA, Fernandez H, Merriam CV, Goldstein EJ.

Anaerobe. 2005 Dec;11(6):315-7. Epub 2005 Jul 5.

PMID:
16701592
26.

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Jan;50(1):379-81.

27.

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.

Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez H.

Antimicrob Agents Chemother. 2006 Jan;50(1):148-55.

28.

Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

Warren YA, Citron DM, Merriam CV, Goldstein EJ.

J Clin Microbiol. 2005 Aug;43(8):4041-5.

30.

In vitro activities of iodonium salts against oral and dental anaerobes.

Goldstein EJ, Citron DM, Warren Y, Merriam CV, Tyrrell K, Fernandez H, Radhakrishnan U, Stang PJ, Conrads G.

Antimicrob Agents Chemother. 2004 Jul;48(7):2766-70.

31.
32.

In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2003 Sep;47(9):3008-11.

33.

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.

Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.

Antimicrob Agents Chemother. 2003 Jul;47(7):2334-8.

34.

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria.

Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell K, Fernandez HT.

Antimicrob Agents Chemother. 2003 Jun;47(6):1968-71.

35.

In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.

Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrel KL, Fernandez H.

Antimicrob Agents Chemother. 2003 Jun;47(6):1963-7.

36.

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2003 Jan;47(1):337-41. Erratum in: Antimicrob Agents Chemother. 2003 Apr;47(4):1486.

37.

In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2002 Dec;46(12):3995-6.

38.
39.

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2002 Sep;46(9):3068-70.

40.
41.

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Apr;46(4):1141-3.

42.

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Apr;46(4):1136-40.

43.
44.

In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Mar;46(3):866-70.

45.
46.

In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Goldstein EJ, Conrads G, Citron DM, Merriam CV, Warren Y, Tyrrell K.

Antimicrob Agents Chemother. 2001 Aug;45(8):2363-7.

47.

Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.

Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell K.

Antimicrob Agents Chemother. 2000 Oct;44(10):2747-51.

48.
49.
50.

In vitro activity of gemifloxacin (SB 265805) against anaerobes.

Goldstein EJ, Citron DM, Warren Y, Tyrrell K, Merriam CV.

Antimicrob Agents Chemother. 1999 Sep;43(9):2231-5.

Supplemental Content

Loading ...
Support Center